Lipoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lipoma}} | {{Lipoma}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Sahar}} | ||
{{ | |||
==Overview== | ==Overview== | ||
There are no established measures for the [[secondary prevention]] of lipoma. | |||
==Secondary Prevention== | |||
There are no established measures for the [[secondary prevention]] of lipoma. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 17:19, 22 November 2019
Lipoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lipoma secondary prevention On the Web |
American Roentgen Ray Society Images of Lipoma secondary prevention |
Risk calculators and risk factors for Lipoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
There are no established measures for the secondary prevention of lipoma.
Secondary Prevention
There are no established measures for the secondary prevention of lipoma.